Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.71B |
| 2 |
Eli Lilly
LLY
|
+$1.55B |
| 3 |
Tesla
TSLA
|
+$1.14B |
| 4 |
Boeing
BA
|
+$935M |
| 5 |
TE Connectivity
TEL
|
+$910M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.79B |
| 2 |
Visa
V
|
+$1.57B |
| 3 |
General Dynamics
GD
|
+$1.55B |
| 4 |
Morgan Stanley
MS
|
+$1.29B |
| 5 |
Exelon
EXC
|
+$1.15B |
Sector Composition
| 1 | Technology | 24.19% |
| 2 | Healthcare | 17.87% |
| 3 | Financials | 14.67% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1476
DELISTED
Verve Therapeutics
VERV
| $2.04M | ﹤0.01% |
361,498
+14,469
| +4% | +$81.6K |
|
1477
NetApp
NTAP
$24.9B
| $2.03M | ﹤0.01% |
17,461
+2,463
| +16% | +$286K |
|
1478
CNA Financial
CNA
$13B
| $2.02M | ﹤0.01% |
41,670
+619
| +2% | +$29.9K |
|
1479
DexCom
DXCM
$29.7B
| $2.01M | ﹤0.01% |
25,841
-5,672,673
| -100% | -$441M |
|
1480
iQIYI
IQ
$2.48B
| $2M | ﹤0.01% |
+994,172
| New | +$2M |
|
1481
Conagra Brands
CAG
$9.21B
| $2M | ﹤0.01% |
71,994
-1,297
| -2% | -$36K |
|
1482
Allison Transmission
ALSN
$7.46B
| $1.99M | ﹤0.01% |
18,456
+1,871
| +11% | +$202K |
|
1483
Fidelity National Financial
FNF
$16.4B
| $1.98M | ﹤0.01% |
35,223
+28,468
| +421% | +$1.6M |
|
|
PARA
1484
DELISTED
Paramount Global Class B
PARA
| $1.96M | ﹤0.01% |
187,453
+85,047
| +83% | +$890K |
|
|
ARTV
1485
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$65M
| $1.95M | ﹤0.01% |
194,108
| – | – |
|
|
BBOT
1486
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$832M
| $1.94M | ﹤0.01% |
184,590
-80
| -0% | -$840 |
|
|
CNTA
1487
Centessa Pharmaceuticals
CNTA
$3.04B
| $1.93M | ﹤0.01% |
115,107
+14,494
| +14% | +$243K |
|
1488
IQVIA
IQV
$31.9B
| $1.92M | ﹤0.01% |
9,791
+1,106
| +13% | +$217K |
|
|
WBA
1489
DELISTED
Walgreens Boots Alliance
WBA
| $1.91M | ﹤0.01% |
204,979
+11,453
| +6% | +$107K |
|
1490
TG Therapeutics
TGTX
$5.04B
| $1.91M | ﹤0.01% |
63,513
-9,807
| -13% | -$295K |
|
1491
GE HealthCare
GEHC
$35.2B
| $1.9M | ﹤0.01% |
24,341
+3,575
| +17% | +$279K |
|
1492
Corcept Therapeutics
CORT
$7.75B
| $1.9M | ﹤0.01% |
37,719
-3,347
| -8% | -$169K |
|
1493
Citizens Community Bancorp
CZWI
$165M
| $1.9M | ﹤0.01% |
116,644
| – | – |
|
1494
Mesa Laboratories
MLAB
$330M
| $1.89M | ﹤0.01% |
+14,314
| New | +$1.89M |
|
1495
Fortis
FTS
$24.8B
| $1.89M | ﹤0.01% |
45,431
+1,577
| +4% | +$65.5K |
|
1496
Theravance Biopharma
TBPH
$724M
| $1.87M | ﹤0.01% |
198,491
+7,162
| +4% | +$67.4K |
|
|
MZTI
1497
The Marzetti Company Common Stock
MZTI
$5.06B
| $1.86M | ﹤0.01% |
10,771
-72,859
| -87% | -$12.6M |
|
|
ORKA
1498
Oruka Therapeutics, Inc. Common Stock
ORKA
$596M
| $1.84M | ﹤0.01% |
95,089
+12,952
| +16% | +$251K |
|
1499
Krystal Biotech
KRYS
$4.16B
| $1.83M | ﹤0.01% |
11,704
-976
| -8% | -$153K |
|
1500
Teradyne
TER
$17.9B
| $1.83M | ﹤0.01% |
14,554
+3,870
| +36% | +$487K |
|